,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Superior mesenteric artery syndrome,6,16539267
0,22.0,Death,5,16539272
0,22.0,Colitis ischaemic,,16539283
0,22.0,Acute kidney injury,6,16539307
0,22.0,Joint stiffness,2,16539324
1,22.0,Arthralgia,2,16539324
0,22.0,Temperature intolerance,6,16539333
1,22.0,Thermohyperaesthesia,6,16539333
0,22.0,Fluid retention,2,16539337
0,22.0,Neuropathy peripheral,6,16539357
1,22.0,Fistula,6,16539357
0,22.0,Pain of skin,1,16539358
1,22.0,Respiratory symptom,1,16539358
2,22.0,Bone marrow failure,6,16539358
3,22.0,Diarrhoea,6,16539358
4,22.0,Nausea,6,16539358
5,22.0,Pyrexia,1,16539358
6,22.0,Neuropathy peripheral,1,16539358
7,22.0,Fatigue,6,16539358
8,22.0,Intentional dose omission,6,16539358
0,22.0,Neurotoxicity,6,16539359
0,22.0,Electrolyte imbalance,6,16539363
1,22.0,Hypotension,6,16539363
2,22.0,Decreased appetite,6,16539363
3,22.0,Dehydration,6,16539363
0,22.0,Meningioma,5,16539364
0,22.0,Neuropathy peripheral,6,16539365
0,22.0,Neuropathy peripheral,6,16539370
0,22.0,Diarrhoea,6,16539395
1,22.0,Neurotoxicity,6,16539395
0,22.0,Death,5,16539398
0,22.0,Proteinuria,6,16539404
0,22.0,Bone pain,6,16539448
1,22.0,Thrombosis,6,16539448
0,22.0,Dry skin,1,16539465
1,22.0,Weight decreased,1,16539465
2,22.0,Alopecia,3,16539465
0,22.0,Hospitalisation,6,16539510
1,22.0,Weight decreased,6,16539510
2,22.0,Constipation,3,16539510
3,22.0,Dysphonia,6,16539510
4,22.0,Diarrhoea,2,16539510
5,22.0,Oral pain,4,16539510
6,22.0,Cystitis,6,16539510
7,22.0,Dehydration,6,16539510
8,22.0,Tongue discomfort,2,16539510
9,22.0,Decreased appetite,6,16539510
10,22.0,Blood magnesium decreased,6,16539510
11,22.0,Dysphagia,6,16539510
12,22.0,Oral pain,6,16539510
13,22.0,Stomatitis,2,16539510
0,22.0,Constipation,,16539526
0,22.0,Erythema,2,16539531
1,22.0,Nausea,1,16539531
2,22.0,Dizziness,2,16539531
3,22.0,Hypotension,1,16539531
4,22.0,Rash,1,16539531
5,22.0,Throat tightness,1,16539531
6,22.0,Anaphylactic shock,4,16539531
7,22.0,Vomiting,2,16539531
8,22.0,Wrong technique in product usage process,6,16539531
9,22.0,Malaise,1,16539531
10,22.0,Hypersensitivity,2,16539531
0,22.0,Pneumonia,,16539538
0,22.0,Pulmonary embolism,,16539540
1,22.0,Disease progression,,16539540
2,22.0,Asthenia,,16539540
0,22.0,Weight decreased,1,16539547
0,22.0,Anaphylactoid reaction,1,16539557
0,22.0,Death,,16539597
0,22.1,Pain in extremity,2,16539610
1,22.1,Nausea,1,16539610
2,22.1,Product use issue,6,16539610
3,22.1,Arthralgia,2,16539610
4,22.1,Dysphonia,2,16539610
5,22.1,Neuropathy peripheral,3,16539610
6,22.1,Tooth fracture,1,16539610
7,22.1,Fatigue,3,16539610
8,22.1,Joint swelling,1,16539610
9,22.1,Arthralgia,2,16539610
10,22.1,Skin exfoliation,3,16539610
11,22.1,Dizziness,1,16539610
12,22.1,Constipation,3,16539610
13,22.1,Gait disturbance,2,16539610
14,22.1,Off label use,,16539610
0,22.0,Death,,16539619
0,22.0,Death,,16539639
0,22.0,Death,,16539675
0,22.0,Dementia,,16539681
0,22.1,Neutropenia,6,16539684
1,22.1,White blood cell count decreased,3,16539684
2,22.1,Malaise,6,16539684
0,22.0,Accident,6,16539694
0,22.1,Fatigue,6,16539697
1,22.1,Bone pain,6,16539697
2,22.1,Alopecia,6,16539697
3,22.1,Diarrhoea,6,16539697
4,22.1,Gait disturbance,6,16539697
5,22.1,Dysphagia,6,16539697
6,22.1,Vision blurred,6,16539697
0,22.0,Blister,6,16539708
1,22.0,Oropharyngeal pain,6,16539708
0,22.0,Neoplasm progression,6,16539716
0,22.0,Infection,6,16539730
1,22.0,Infection susceptibility increased,6,16539730
0,22.1,Blood urea increased,6,16539737
1,22.1,Blood creatinine increased,6,16539737
2,22.1,Diarrhoea,3,16539737
3,22.1,Renal impairment,6,16539737
4,22.1,Faeces pale,3,16539737
5,22.1,Fatigue,3,16539737
0,22.0,Product dose omission,6,16539741
1,22.0,White blood cell count abnormal,6,16539741
0,22.0,Nausea,,16539742
1,22.0,Asthenia,,16539742
2,22.0,Fatigue,,16539742
3,22.0,Decreased appetite,,16539742
0,22.0,Neoplasm progression,6,16539775
0,22.0,Pleural effusion,6,16539781
1,22.0,Carbohydrate antigen 125 increased,6,16539781
2,22.0,Tachycardia,3,16539781
3,22.0,Fatigue,3,16539781
4,22.0,Decreased appetite,3,16539781
0,22.1,Poor venous access,6,16539793
1,22.1,Fatigue,6,16539793
2,22.1,Arthritis,6,16539793
3,22.1,Feeling abnormal,6,16539793
4,22.1,Musculoskeletal pain,6,16539793
5,22.1,Myalgia,6,16539793
6,22.1,Dry eye,6,16539793
7,22.1,Arthropathy,6,16539793
8,22.1,Arthralgia,6,16539793
0,22.1,Herpes zoster,1,16539848
0,22.1,Fall,6,16539877
1,22.1,Product use in unapproved indication,6,16539877
2,22.1,Off label use,6,16539877
3,22.1,Pre-existing condition improved,2,16539877
0,22.1,Alopecia,6,16539878
0,22.1,Bronchitis,2,16539900
0,22.0,Rash vesicular,3,16539914
1,22.0,Rash pruritic,3,16539914
2,22.0,Tonsillar disorder,6,16539914
0,22.1,Bedridden,6,16539944
0,22.0,Bone pain,6,16539953
1,22.0,Arthralgia,6,16539953
2,22.0,Pain,6,16539953
3,22.0,Pyrexia,6,16539953
4,22.0,Off label use,6,16539953
5,22.0,Lyme disease,6,16539953
6,22.0,Platelet count decreased,6,16539953
7,22.0,Musculoskeletal pain,6,16539953
8,22.0,Influenza like illness,3,16539953
9,22.0,Product use in unapproved indication,6,16539953
10,22.0,Fatigue,3,16539953
0,22.0,Drug ineffective,3,16540005
1,22.0,Product adhesion issue,3,16540005
2,22.0,Drug interaction,3,16540005
3,22.0,Product storage error,3,16540005
0,22.0,Death,5,16540064
0,22.0,Neuropathy peripheral,6,16540082
1,22.0,Photosensitivity reaction,6,16540082
2,22.0,Thrombocytopenia,6,16540082
3,22.0,Psychomotor hyperactivity,6,16540082
4,22.0,Insomnia,6,16540082
0,22.0,Drug resistance,6,16540123
1,22.0,Malignant neoplasm progression,6,16540123
0,22.0,Neurotoxicity,6,16540124
1,22.0,Neuropathy peripheral,6,16540124
0,22.1,Malaise,6,16540151
1,22.1,Decreased appetite,3,16540151
2,22.1,Fatigue,6,16540151
3,22.1,Asthenia,6,16540151
4,22.1,Product dose omission,6,16540151
0,22.0,Alopecia,3,16540155
1,22.0,Hair colour changes,3,16540155
2,22.0,Hair texture abnormal,3,16540155
3,22.0,Hair disorder,3,16540155
4,22.0,Madarosis,3,16540155
0,22.0,Neutrophil count decreased,6,16540157
1,22.0,Asthenia,6,16540157
2,22.0,White blood cell count decreased,6,16540157
0,22.0,Cardiac tamponade,3,16540165
0,22.0,Agranulocytosis,1,16540177
0,22.0,Renal cancer,,16540181
0,22.0,Febrile neutropenia,3,16540228
0,22.0,Extravasation,2,16540257
0,22.1,Dizziness,1,16540311
1,22.1,Diarrhoea,2,16540311
2,22.1,White blood cell count increased,3,16540311
3,22.1,Sleep disorder,3,16540311
4,22.1,Breast tenderness,1,16540311
5,22.1,Constipation,3,16540311
6,22.1,Decreased appetite,1,16540311
7,22.1,Erythema,6,16540311
0,22.0,Bradycardia,1,16540336
1,22.0,Angina pectoris,1,16540336
0,22.0,Hypertension,6,16540339
1,22.0,Neuropathy peripheral,6,16540339
0,22.0,Neuropathy peripheral,6,16540340
0,22.0,Decreased appetite,3,16540341
1,22.0,Hypersensitivity,3,16540341
2,22.0,Protein urine present,3,16540341
3,22.0,Asthenia,3,16540341
4,22.0,Back pain,3,16540341
5,22.0,Epistaxis,3,16540341
6,22.0,Platelet count decreased,3,16540341
7,22.0,Haemorrhoidal haemorrhage,3,16540341
8,22.0,Diarrhoea,3,16540341
0,22.0,Neuropathy peripheral,6,16540344
0,22.0,Toxicity to various agents,6,16540346
0,22.0,Toxicity to various agents,6,16540347
0,22.0,Thrombophlebitis,6,16540348
0,22.0,Decreased appetite,6,16540353
1,22.0,Nausea,6,16540353
2,22.0,Thrombosis,6,16540353
0,22.1,Pelvic venous thrombosis,3,16540355
1,22.1,Deep vein thrombosis,3,16540355
2,22.1,Phlebitis,3,16540355
0,22.1,Death,5,16540358
1,22.1,Abdominal discomfort,3,16540358
2,22.1,Haemoglobin decreased,6,16540358
3,22.1,Dehydration,6,16540358
4,22.1,Vomiting,3,16540358
5,22.1,Diarrhoea,3,16540358
0,22.0,Bone pain,3,16540371
1,22.0,Dehydration,3,16540371
2,22.0,Death,5,16540371
3,22.0,Pain in jaw,3,16540371
4,22.0,Malaise,3,16540371
0,22.0,Gamma-glutamyltransferase increased,1,16540395
0,22.0,Feeding disorder,2,16540411
1,22.0,Discomfort,2,16540411
2,22.0,Nausea,2,16540411
3,22.0,Malignant neoplasm progression,6,16540411
4,22.0,Drug resistance,3,16540411
5,22.0,Product use complaint,6,16540411
6,22.0,Weight decreased,6,16540411
0,22.0,Death,5,16540415
1,22.0,Drug resistance,6,16540415
2,22.0,Malignant neoplasm progression,6,16540415
0,22.0,Drug ineffective,6,16540418
1,22.0,Malignant neoplasm progression,6,16540418
2,22.0,Drug resistance,6,16540418
0,22.0,Bicytopenia,6,16540426
0,22.0,Impaired healing,6,16540474
1,22.0,Jaw disorder,6,16540474
0,22.0,Death,5,16540491
0,22.0,Renal impairment,6,16540554
0,22.0,Renal impairment,6,16540555
0,22.0,Epistaxis,6,16540558
1,22.0,Neoplasm progression,2,16540558
2,22.0,Off label use,6,16540558
3,22.0,Product use in unapproved indication,6,16540558
0,22.0,Alopecia,2,16540617
0,22.1,White blood cell count decreased,6,16540625
1,22.1,Hypoacusis,6,16540625
0,22.0,Alopecia,2,16540628
1,22.0,Psychological trauma,6,16540628
0,22.0,Alopecia,2,16540675
0,22.0,Neuropathy peripheral,6,16540688
1,22.0,Condition aggravated,6,16540688
2,22.0,Deep vein thrombosis,6,16540688
3,22.0,Ascites,6,16540688
0,22.0,Malignant neoplasm progression,6,16540697
1,22.0,Drug resistance,6,16540697
0,22.0,Malignant neoplasm progression,6,16540708
1,22.0,Discomfort,6,16540708
2,22.0,Drug resistance,6,16540708
3,22.0,Rash,1,16540708
4,22.0,Diarrhoea,1,16540708
5,22.0,Pain,6,16540708
0,22.0,Ear operation,3,16540759
1,22.0,Oropharyngeal pain,3,16540759
0,22.0,Hormone-refractory prostate cancer,5,16540775
0,22.0,Hormone-refractory prostate cancer,6,16540776
0,22.0,Alopecia,2,16540851
1,22.0,Psychological trauma,6,16540851
0,22.0,Alopecia,2,16540882
0,22.0,Alopecia,2,16540888
0,22.1,Alopecia,2,16540895
0,22.1,Alopecia,2,16540906
0,22.0,Alopecia,2,16540921
1,22.0,Psychological trauma,6,16540921
0,22.0,Bone marrow failure,2,16541022
1,22.0,Oral pain,1,16541022
2,22.0,Fatigue,2,16541022
3,22.0,Pain,2,16541022
4,22.0,Full blood count decreased,6,16541022
5,22.0,Abdominal pain upper,1,16541022
6,22.0,Decreased appetite,2,16541022
7,22.0,Intentional product misuse,6,16541022
8,22.0,Neutropenia,1,16541022
9,22.0,Stomatitis,1,16541022
10,22.0,Hypoaesthesia oral,6,16541022
11,22.0,Diarrhoea,1,16541022
0,22.0,Nausea,3,16541061
1,22.0,Dysphonia,3,16541061
2,22.0,Plantar erythema,3,16541061
3,22.0,Decreased appetite,3,16541061
4,22.0,Dry mouth,3,16541061
5,22.0,Fatigue,3,16541061
6,22.0,Cerebrovascular accident,,16541061
7,22.0,Gait disturbance,3,16541061
8,22.0,Weight decreased,3,16541061
9,22.0,Off label use,,16541061
10,22.0,Neuralgia,3,16541061
11,22.0,Dizziness,3,16541061
12,22.0,Neuropathy peripheral,3,16541061
13,22.0,Neoplasm,3,16541061
0,22.0,Death,5,16541113
1,22.0,Decreased appetite,2,16541113
2,22.0,Hormone-refractory prostate cancer,,16541113
3,22.0,Metastasis,,16541113
0,22.0,Neoplasm progression,6,16541119
0,22.1,Nausea,6,16541121
1,22.1,Neoplasm progression,5,16541121
0,22.0,Product use in unapproved indication,6,16541122
1,22.0,Off label use,6,16541122
2,22.0,Neoplasm progression,5,16541122
0,22.0,Diarrhoea,1,16541125
1,22.0,Asthenia,1,16541125
2,22.0,Off label use,6,16541125
3,22.0,Hypokalaemia,1,16541125
4,22.0,Malaise,1,16541125
0,22.0,Drug resistance,6,16541138
1,22.0,Loss of personal independence in daily activities,6,16541138
2,22.0,Malignant neoplasm progression,6,16541138
3,22.0,Dyspnoea,6,16541138
4,22.0,Hydrothorax,6,16541138
0,22.0,Bladder tamponade,6,16541140
1,22.0,Anaemia,6,16541140
2,22.0,Hormone-refractory prostate cancer,,16541140
0,22.0,Arthralgia,6,16541181
1,22.0,Constipation,6,16541181
2,22.0,Polyp,6,16541181
3,22.0,Skin wrinkling,6,16541181
4,22.0,Myalgia,6,16541181
5,22.0,Hair colour changes,6,16541181
6,22.0,Arthritis,6,16541181
7,22.0,Diverticulitis,6,16541181
8,22.0,Gait disturbance,6,16541181
9,22.0,Abdominal pain upper,6,16541181
10,22.0,Breast mass,6,16541181
0,22.0,Prescribed underdose,6,16541194
1,22.0,Liver injury,6,16541194
0,22.1,Acute kidney injury,2,16541210
1,22.1,Neutropenia,1,16541210
0,22.0,Bone marrow failure,3,16541213
1,22.0,Hormone-refractory prostate cancer,3,16541213
0,22.0,Deep vein thrombosis,1,16541226
0,22.0,Death,5,16541274
1,22.0,Off label use,6,16541274
2,22.0,Product prescribing error,6,16541274
3,22.0,Prostate cancer,6,16541274
0,22.0,Malignant neoplasm progression,6,16541278
1,22.0,Drug resistance,6,16541278
0,22.0,Malignant neoplasm progression,6,16541279
1,22.0,Drug resistance,6,16541279
0,22.0,Malignant neoplasm progression,6,16541287
1,22.0,Drug resistance,6,16541287
0,22.0,Malignant neoplasm progression,6,16541288
1,22.0,Drug resistance,6,16541288
0,22.0,Malignant neoplasm progression,6,16541289
1,22.0,Drug resistance,6,16541289
0,22.0,Malignant neoplasm progression,6,16541290
1,22.0,Drug resistance,6,16541290
0,22.0,Drug resistance,6,16541291
1,22.0,Malignant neoplasm progression,6,16541291
0,22.0,Hot flush,6,16541294
1,22.0,Off label use,6,16541294
2,22.0,Fatigue,6,16541294
3,22.0,Product use in unapproved indication,6,16541294
4,22.0,Metastasis,6,16541294
0,22.0,Urticaria,1,16541308
0,22.0,Oxygen saturation decreased,6,16541331
1,22.0,Death,5,16541331
2,22.0,Pleural effusion,6,16541331
3,22.0,Dyspnoea,6,16541331
0,22.0,Malignant neoplasm progression,6,16541332
1,22.0,Pain,6,16541332
2,22.0,Drug resistance,6,16541332
3,22.0,Diarrhoea,1,16541332
4,22.0,Pruritus,1,16541332
0,22.0,Malignant neoplasm progression,6,16541334
1,22.0,Drug resistance,6,16541334
0,22.0,Insomnia,6,16541346
1,22.0,Feeding disorder,6,16541346
2,22.0,Vomiting,6,16541346
3,22.0,Product use in unapproved indication,6,16541346
0,22.0,Febrile neutropenia,5,16541351
1,22.0,Sepsis,5,16541351
0,22.0,General physical health deterioration,5,16541366
0,22.0,Malignant neoplasm progression,6,16541414
1,22.0,Drug resistance,6,16541414
0,22.1,Tongue pigmentation,2,16541415
1,22.1,Neutrophil count decreased,2,16541415
2,22.1,Hepatic function abnormal,2,16541415
3,22.1,Anaemia,6,16541415
0,22.0,Drug resistance,6,16541416
1,22.0,Malignant neoplasm progression,6,16541416
0,22.0,Hypophosphataemia,1,16541432
1,22.0,Hypocalcaemia,1,16541432
0,22.0,Platelet count decreased,6,16541440
1,22.0,Renal injury,6,16541440
2,22.0,Renal impairment,6,16541440
0,22.0,Drug interaction,1,16541448
1,22.0,Rectal haemorrhage,1,16541448
2,22.0,Epistaxis,1,16541448
0,22.0,Malignant neoplasm progression,6,16541501
1,22.0,Drug resistance,6,16541501
0,22.0,Hepatic cirrhosis,5,16541552
0,22.0,Malignant neoplasm progression,6,16541579
1,22.0,Drug resistance,6,16541579
0,22.0,Interstitial lung disease,5,16541580
0,22.1,Metastases to bone,6,16541620
1,22.1,Breast cancer metastatic,6,16541620
2,22.1,Drug intolerance,6,16541620
3,22.1,Skin mass,6,16541620
4,22.1,Malignant neoplasm progression,6,16541620
0,22.0,Metastases to meninges,6,16541631
1,22.0,Malignant neoplasm progression,6,16541631
2,22.0,Drug resistance,6,16541631
0,22.0,Neoplasm progression,6,16541649
1,22.0,Vomiting,3,16541649
2,22.0,Fatigue,6,16541649
3,22.0,Death,5,16541649
4,22.0,Nausea,6,16541649
5,22.0,Malaise,6,16541649
0,22.1,Constipation,3,16541650
1,22.1,Abdominal pain upper,3,16541650
2,22.1,Diarrhoea,3,16541650
3,22.1,Abdominal pain,3,16541650
4,22.1,Intra-abdominal fluid collection,3,16541650
5,22.1,Oxygen saturation decreased,3,16541650
6,22.1,Adverse event,3,16541650
0,22.1,Malignant neoplasm progression,5,16541664
1,22.1,Condition aggravated,6,16541664
0,22.0,Drug ineffective,1,16541713
1,22.0,Hypersensitivity,1,16541713
2,22.0,Arthralgia,3,16541713
3,22.0,Gait inability,1,16541713
4,22.0,Metastatic neoplasm,3,16541713
0,22.1,Ischaemic stroke,4,16541716
0,22.0,Hepatotoxicity,2,16541773
0,22.0,Nephritis,6,16541776
0,22.0,Musculoskeletal disorder,6,16541784
0,22.0,Diarrhoea,1,16541795
0,22.0,Neuropathy peripheral,3,16541803
1,22.0,Constipation,3,16541803
2,22.0,Pain in extremity,3,16541803
3,22.0,Vomiting,1,16541803
4,22.0,Chills,1,16541803
5,22.0,Cystitis,3,16541803
0,22.0,Cough,3,16541808
1,22.0,Nasopharyngitis,6,16541808
2,22.0,Injection site pain,6,16541808
3,22.0,Needle issue,6,16541808
4,22.0,Serum serotonin increased,6,16541808
5,22.0,Nasal congestion,6,16541808
6,22.0,Myalgia,6,16541808
7,22.0,Dizziness,6,16541808
8,22.0,Inappropriate schedule of product administration,6,16541808
9,22.0,Blood pressure systolic increased,3,16541808
10,22.0,Body temperature decreased,6,16541808
11,22.0,Pain,6,16541808
12,22.0,Product use in unapproved indication,6,16541808
0,22.0,Abdominal distension,3,16541821
1,22.0,General physical health deterioration,3,16541821
2,22.0,Asthenia,3,16541821
0,22.0,Neoplasm progression,6,16541903
0,22.1,Hyponatraemia,2,16541925
0,22.0,Liver disorder,1,16541994
0,22.0,Death,5,16541995
0,22.0,Arthropathy,6,16541999
0,22.0,Death,5,16542000
0,22.0,Swelling face,3,16542001
1,22.0,Scrotal exfoliation,3,16542001
2,22.0,Weight decreased,6,16542001
3,22.0,Pleural effusion,6,16542001
4,22.0,Diarrhoea,3,16542001
5,22.0,Rash,1,16542001
6,22.0,Infection,6,16542001
7,22.0,Dry mouth,1,16542001
8,22.0,Skin exfoliation,1,16542001
9,22.0,Genital tract inflammation,6,16542001
10,22.0,Pain in jaw,1,16542001
11,22.0,Nausea,1,16542001
12,22.0,Pain in extremity,3,16542001
13,22.0,Dizziness,1,16542001
14,22.0,Acne,3,16542001
0,22.0,Urinary tract infection,2,16542044
0,22.1,Febrile neutropenia,1,16542125
1,22.1,Dehydration,1,16542125
0,22.0,Death,5,16542225
1,22.0,Intentional product use issue,6,16542225
0,22.0,Haematotoxicity,1,16542263
0,22.0,Confusional state,3,16542294
1,22.0,Anxiety,6,16542294
2,22.0,Sleep terror,6,16542294
3,22.0,Thinking abnormal,6,16542294
4,22.0,Decreased appetite,6,16542294
5,22.0,Nausea,3,16542294
6,22.0,Gait inability,6,16542294
7,22.0,Incorrect dose administered,6,16542294
8,22.0,Paranoia,6,16542294
9,22.0,Asthenia,6,16542294
0,22.0,Ageusia,6,16542297
1,22.0,Liver function test abnormal,2,16542297
2,22.0,Hunger,6,16542297
3,22.0,Retching,6,16542297
4,22.0,Pain in extremity,6,16542297
5,22.0,Protein urine present,6,16542297
6,22.0,Back pain,6,16542297
7,22.0,Renal impairment,6,16542297
8,22.0,Haematochezia,6,16542297
9,22.0,Body fat disorder,6,16542297
10,22.0,Constipation,6,16542297
11,22.0,Feeding disorder,6,16542297
12,22.0,Diarrhoea,6,16542297
0,22.0,Hypotension,3,16542311
1,22.0,Metastases to biliary tract,3,16542311
2,22.0,Abdominal distension,3,16542311
3,22.0,Hepatic failure,5,16542311
4,22.0,Jaundice,3,16542311
0,22.0,Tumour marker decreased,6,16542314
1,22.0,Vein disorder,6,16542314
2,22.0,Myalgia,6,16542314
3,22.0,Menopause,6,16542314
4,22.0,Pain,6,16542314
5,22.0,Restlessness,6,16542314
6,22.0,Arthralgia,6,16542314
0,22.0,Thrombocytopenia,6,16542361
1,22.0,Neutropenia,6,16542361
2,22.0,Vomiting,6,16542361
3,22.0,Decreased appetite,6,16542361
4,22.0,Nausea,6,16542361
0,22.1,Cytokine release syndrome,1,16542402
0,22.0,Renal function test abnormal,6,16542445
1,22.0,Red blood cell count decreased,6,16542445
2,22.0,Platelet count decreased,6,16542445
3,22.0,White blood cell count decreased,6,16542445
0,22.0,Metastases to the mediastinum,6,16542531
1,22.0,Breast cancer,6,16542531
2,22.0,Blood calcium increased,6,16542531
3,22.0,Metastases to ovary,6,16542531
4,22.0,Malignant neoplasm progression,6,16542531
5,22.0,Metastases to peritoneum,6,16542531
0,22.0,Pruritus,6,16542561
1,22.0,Fatigue,6,16542561
2,22.0,Metastases to kidney,6,16542561
3,22.0,Chronic obstructive pulmonary disease,6,16542561
4,22.0,Blood creatinine increased,6,16542561
0,22.0,Anaemia,1,16542651
0,22.1,Renal pain,6,16542692
1,22.1,Nephrolithiasis,6,16542692
2,22.1,Palliative care,6,16542692
3,22.1,Weight decreased,6,16542692
4,22.1,Intestinal obstruction,6,16542692
5,22.1,Metastases to bone,6,16542692
6,22.1,Volvulus,6,16542692
7,22.1,Haematuria,6,16542692
8,22.1,Death,5,16542692
9,22.1,Stent removal,6,16542692
0,22.0,Colitis,6,16542753
0,22.0,Hepatitis acute,2,16542762
0,22.0,Gastrointestinal perforation,6,16542790
1,22.0,Diarrhoea,6,16542790
2,22.0,Bone marrow failure,6,16542790
0,22.0,Drug intolerance,6,16542796
1,22.0,Asthenia,6,16542796
2,22.0,Anxiety,6,16542796
3,22.0,Myalgia,6,16542796
4,22.0,Hypoaesthesia,6,16542796
5,22.0,Alopecia,6,16542796
6,22.0,Decreased appetite,6,16542796
7,22.0,Dry mouth,6,16542796
0,22.1,Drug interaction,1,16542818
1,22.1,Hypoglycaemia,1,16542818
0,22.1,Neutropenic sepsis,1,16542855
1,22.1,Acute kidney injury,1,16542855
2,22.1,Vomiting,1,16542855
3,22.1,Pulmonary embolism,1,16542855
4,22.1,Nausea,1,16542855
0,22.0,Intentional product use issue,6,16542857
1,22.0,Renal impairment,3,16542857
2,22.0,Hypertension,6,16542857
3,22.0,Off label use,6,16542857
0,22.0,Type I hypersensitivity,1,16542894
0,22.0,Type I hypersensitivity,1,16542895
0,22.0,Type I hypersensitivity,1,16542899
0,22.0,Type I hypersensitivity,1,16542900
0,22.1,Restlessness,6,16542909
1,22.1,Delirium,6,16542909
2,22.1,Interstitial lung disease,5,16542909
3,22.1,Respiratory acidosis,6,16542909
4,22.1,Lung disorder,6,16542909
5,22.1,Fall,6,16542909
6,22.1,Dehydration,6,16542909
7,22.1,Altered state of consciousness,6,16542909
8,22.1,Pneumonia bacterial,6,16542909
9,22.1,Deep vein thrombosis,2,16542909
10,22.1,Depressed level of consciousness,6,16542909
0,22.0,Type I hypersensitivity,1,16542923
0,22.0,Type I hypersensitivity,1,16542926
0,22.0,Type I hypersensitivity,1,16542944
0,22.0,Type I hypersensitivity,1,16542945
0,22.0,Type I hypersensitivity,1,16542946
0,22.0,Neurotoxicity,6,16542956
1,22.0,Nephrotic syndrome,6,16542956
2,22.0,Neutropenia,6,16542956
3,22.0,Haematotoxicity,6,16542956
0,22.0,Peripheral swelling,6,16542957
1,22.0,Erythema,6,16542957
2,22.0,Infusion site extravasation,1,16542957
3,22.0,Blister,6,16542957
0,22.0,Type I hypersensitivity,1,16542981
0,22.0,Type I hypersensitivity,1,16542983
0,22.0,Product use complaint,6,16542985
1,22.0,Loss of consciousness,6,16542985
0,22.1,Coronary artery disease,2,16543008
1,22.1,Mitral valve incompetence,2,16543008
2,22.1,Congestive cardiomyopathy,2,16543008
3,22.1,Cardiotoxicity,2,16543008
4,22.1,Cardiac dysfunction,2,16543008
5,22.1,Bundle branch block left,2,16543008
6,22.1,Cardiac failure chronic,2,16543008
7,22.1,Left ventricular dysfunction,2,16543008
0,22.0,Abdominal discomfort,3,16543019
1,22.0,Weight decreased,3,16543019
2,22.0,Urticaria,1,16543019
3,22.0,Rash generalised,1,16543019
4,22.0,Decreased appetite,3,16543019
5,22.0,Cough,3,16543019
0,22.1,Pain,2,16543022
1,22.1,Extravasation,2,16543022
0,22.0,Lung cancer metastatic,5,16543080
0,22.0,Hot flush,3,16543084
1,22.0,Blood glucose increased,3,16543084
2,22.0,Pulmonary mass,3,16543084
3,22.0,Monocyte count increased,3,16543084
4,22.0,Red blood cell count decreased,3,16543084
5,22.0,Rash pruritic,1,16543084
6,22.0,Abdominal distension,3,16543084
7,22.0,White blood cell count increased,3,16543084
8,22.0,Rash,3,16543084
9,22.0,Pain,3,16543084
10,22.0,Gastroenteritis viral,3,16543084
11,22.0,Oropharyngeal discomfort,3,16543084
12,22.0,Back pain,3,16543084
13,22.0,Alopecia,3,16543084
14,22.0,Heart rate increased,3,16543084
15,22.0,White blood cell count decreased,3,16543084
16,22.0,Blood pressure fluctuation,3,16543084
17,22.0,Red cell distribution width increased,3,16543084
18,22.0,Dizziness,3,16543084
19,22.0,Abdominal pain upper,3,16543084
20,22.0,Constipation,3,16543084
21,22.0,Platelet count increased,3,16543084
22,22.0,Cardiac neoplasm unspecified,3,16543084
23,22.0,Carbohydrate antigen 125 increased,3,16543084
24,22.0,Blood alkaline phosphatase increased,3,16543084
25,22.0,Fatigue,3,16543084
26,22.0,Lymphadenopathy,3,16543084
27,22.0,Blood pressure increased,3,16543084
28,22.0,Angina bullosa haemorrhagica,3,16543084
29,22.0,Chest pain,3,16543084
30,22.0,Headache,3,16543084
0,22.0,Diarrhoea,3,16543111
0,22.0,Exposure during pregnancy,6,16543127
0,22.0,Feeling abnormal,6,16543157
1,22.0,Palpitations,6,16543157
2,22.0,Hypervigilance,6,16543157
3,22.0,Nausea,6,16543157
4,22.0,Somnolence,6,16543157
0,22.1,Stomatitis,3,16543158
1,22.1,Abdominal discomfort,6,16543158
2,22.1,Treatment failure,3,16543158
3,22.1,White blood cell count decreased,6,16543158
4,22.1,Bacterial infection,6,16543158
5,22.1,Weight decreased,6,16543158
6,22.1,Hypotension,6,16543158
7,22.1,Anaemia,6,16543158
8,22.1,Red blood cell count decreased,6,16543158
9,22.1,Neoplasm,3,16543158
10,22.1,Diarrhoea,3,16543158
11,22.1,Rash,3,16543158
0,22.0,Death,5,16543169
0,22.1,Hot flush,3,16543172
1,22.1,Drug interaction,6,16543172
2,22.1,Muscular weakness,6,16543172
3,22.1,Asthenia,3,16543172
0,22.0,Intentional product use issue,6,16543175
1,22.0,Multiple organ dysfunction syndrome,5,16543175
0,22.0,Rheumatoid arthritis,2,16543200
1,22.0,Arthralgia,2,16543200
0,22.0,Diarrhoea,3,16543204
1,22.0,General physical health deterioration,3,16543204
0,22.0,Adverse event,6,16543214
1,22.0,Mental disorder,6,16543214
0,22.0,Deep vein thrombosis,6,16543311
1,22.0,Neuropathy peripheral,6,16543311
2,22.0,Ascites,6,16543311
3,22.0,Condition aggravated,6,16543311
0,22.0,Type I hypersensitivity,1,16543358
0,22.0,Type I hypersensitivity,1,16543359
0,22.0,Type I hypersensitivity,1,16543364
0,22.1,Abdominal pain,1,16543441
1,22.1,Anaemia,1,16543441
2,22.1,Off label use,6,16543441
0,22.0,Dizziness,4,16543443
1,22.0,Sensation of foreign body,4,16543443
2,22.0,Paraesthesia,4,16543443
3,22.0,Dyspnoea,4,16543443
0,22.0,Dizziness,6,16543502
1,22.0,Muscular weakness,1,16543502
2,22.0,Muscle spasms,1,16543502
3,22.0,Hypoaesthesia,6,16543502
0,22.0,Gastric neoplasm,1,16543512
0,22.0,Lung disorder,1,16543526
0,22.0,General physical health deterioration,6,16543567
1,22.0,Hyperhidrosis,3,16543567
2,22.0,Loss of consciousness,3,16543567
3,22.0,Fatigue,3,16543567
4,22.0,Irritable bowel syndrome,3,16543567
0,22.0,Thrombosis,6,16543579
1,22.0,International normalised ratio increased,6,16543579
2,22.0,Death,5,16543579
0,22.0,Hypoglycaemia,1,16543596
1,22.0,Drug interaction,6,16543596
0,22.1,Hypophysitis,3,16543602
1,22.1,Thirst,3,16543602
2,22.1,Sjogren^s syndrome,6,16543602
3,22.1,Dermatitis,6,16543602
4,22.1,Adrenal insufficiency,6,16543602
5,22.1,Amylase increased,2,16543602
6,22.1,Stevens-Johnson syndrome,1,16543602
0,22.0,Bone marrow failure,2,16543638
1,22.0,Cytopenia,2,16543638
0,22.0,Atrial fibrillation,5,16543648
1,22.0,Alveolitis,5,16543648
2,22.0,Hypoxia,5,16543648
0,22.0,Off label use,6,16543727
0,22.0,Pneumonia,5,16543739
0,22.0,Blood sodium decreased,1,16543744
1,22.0,Product dose omission,6,16543744
2,22.0,Confusional state,1,16543744
0,22.0,Disseminated Bacillus Calmette-Guerin infection,6,16543745
1,22.0,Bacterial sepsis,6,16543745
0,22.0,Rash,6,16543757
0,22.0,Radiation pneumonitis,5,16543766
1,22.0,Disseminated intravascular coagulation,5,16543766
2,22.0,Lung disorder,6,16543766
0,22.0,Drug ineffective,3,16543767
1,22.0,Back pain,6,16543767
0,22.0,Pericardial effusion,6,16543814
1,22.0,Pleural effusion,6,16543814
2,22.0,Rib fracture,6,16543814
0,22.0,Death,5,16543839
0,22.0,Haematuria,6,16543871
1,22.0,Abdominal pain,6,16543871
2,22.0,Urinary retention,6,16543871
3,22.0,Nausea,6,16543871
0,22.0,Death,5,16543895
0,22.0,Stomatitis,6,16543902
1,22.0,Wheezing,6,16543902
2,22.0,Neoplasm progression,6,16543902
3,22.0,Rash,6,16543902
4,22.0,Deep vein thrombosis,6,16543902
5,22.0,Dyspnoea,6,16543902
6,22.0,Nasal septum perforation,6,16543902
7,22.0,Anaemia,6,16543902
8,22.0,Neutropenia,6,16543902
9,22.0,Skin toxicity,6,16543902
0,22.0,Neutropenia,6,16543905
1,22.0,Leukopenia,6,16543905
2,22.0,Dysgeusia,6,16543905
3,22.0,Thrombocytopenia,6,16543905
4,22.0,Bone marrow failure,6,16543905
5,22.0,Diarrhoea,6,16543905
6,22.0,Oral pain,6,16543905
7,22.0,Nausea,6,16543905
8,22.0,Fatigue,6,16543905
0,22.1,Cerebral haemorrhage,4,16543909
1,22.1,Status epilepticus,1,16543909
0,22.0,Pyrexia,6,16543910
1,22.0,Chordae tendinae rupture,6,16543910
2,22.0,Hypergammaglobulinaemia,6,16543910
3,22.0,Visceral leishmaniasis,1,16543910
4,22.0,C-reactive protein increased,1,16543910
5,22.0,Pancytopenia,1,16543910
6,22.0,Hypoalbuminaemia,6,16543910
7,22.0,Cardiac murmur,6,16543910
8,22.0,Procalcitonin increased,6,16543910
0,22.0,Coma,5,16543933
1,22.0,Malaise,6,16543933
0,22.0,Dyspnoea,6,16543953
1,22.0,Fatigue,6,16543953
2,22.0,Bone marrow failure,6,16543953
3,22.0,Neoplasm progression,6,16543953
0,22.0,Blister,6,16543968
0,22.0,Cardiac failure,6,16543969
1,22.0,Cardiac valve disease,6,16543969
0,22.0,Second primary malignancy,6,16544002
1,22.0,Refractory cytopenia with unilineage dysplasia,6,16544002
0,22.0,Product use in unapproved indication,6,16544013
1,22.0,Therapeutic response unexpected,6,16544013
0,22.0,Reflux gastritis,3,16544014
1,22.0,Abdominal discomfort,3,16544014
2,22.0,Herpes zoster,1,16544014
3,22.0,Peripheral artery occlusion,1,16544014
0,22.0,Inappropriate schedule of product administration,6,16544015
1,22.0,Asthenia,6,16544015
2,22.0,Dizziness,6,16544015
3,22.0,General physical health deterioration,6,16544015
0,22.0,Malignant neoplasm progression,3,16544020
0,22.0,Death,5,16544034
0,22.0,Suffocation feeling,2,16544042
1,22.0,Back pain,2,16544042
0,22.0,Death,5,16544053
0,22.0,Death,5,16544115
1,22.0,Neutropenia,3,16544115
2,22.0,Blood disorder,3,16544115
0,22.0,Dysphagia,3,16544166
1,22.0,Alopecia,2,16544166
2,22.0,Red blood cell count decreased,6,16544166
3,22.0,White blood cell count decreased,6,16544166
0,22.0,Death,5,16544190
1,22.0,Gastrointestinal disorder,6,16544190
2,22.0,Flatulence,6,16544190
3,22.0,Nausea,6,16544190
4,22.0,Abdominal pain upper,6,16544190
0,22.1,Product use issue,3,16544196
1,22.1,Off label use,3,16544196
2,22.1,Abdominal pain upper,3,16544196
3,22.1,Neoplasm progression,3,16544196
0,22.0,Neoplasm recurrence,6,16544202
0,22.1,Therapeutic product effect decreased,6,16544203
1,22.1,Laboratory test abnormal,1,16544203
0,22.0,Death,,16544211
0,22.0,Rash,6,16544223
0,22.0,Diarrhoea,6,16544259
0,22.0,Chest discomfort,1,16544261
1,22.0,Laboratory test abnormal,6,16544261
0,22.1,Adverse event,6,16544280
1,22.1,Delirium,1,16544280
2,22.1,Anxiety,6,16544280
3,22.1,Drug ineffective for unapproved indication,6,16544280
4,22.1,Product use in unapproved indication,6,16544280
5,22.1,Drug intolerance,6,16544280
0,22.0,Oral cavity fistula,1,16544293
1,22.0,Osteonecrosis of jaw,1,16544293
2,22.0,Pain in jaw,1,16544293
3,22.0,Swelling face,1,16544293
4,22.0,Purulence,1,16544293
5,22.0,Sequestrectomy,1,16544293
0,22.0,Sudden death,5,16544307
0,22.0,Chylothorax,2,16544330
1,22.0,Ascites,2,16544330
0,22.0,Burning sensation,6,16544379
1,22.0,Peripheral swelling,6,16544379
2,22.0,Hypoaesthesia,6,16544379
3,22.0,Pain in extremity,6,16544379
4,22.0,Carpal tunnel syndrome,6,16544379
0,22.0,Muscular weakness,6,16544390
1,22.0,Depressed mood,6,16544390
2,22.0,Abdominal distension,6,16544390
3,22.0,Tooth disorder,1,16544390
4,22.0,Urinary tract infection,6,16544390
5,22.0,Photosensitivity reaction,6,16544390
6,22.0,Constipation,6,16544390
7,22.0,Muscle spasms,6,16544390
8,22.0,Arthralgia,3,16544390
9,22.0,Headache,1,16544390
10,22.0,Diarrhoea,6,16544390
11,22.0,Epistaxis,6,16544390
12,22.0,Pruritus,6,16544390
13,22.0,Back pain,6,16544390
14,22.0,Off label use,6,16544390
15,22.0,Restlessness,6,16544390
16,22.0,Nasal dryness,6,16544390
17,22.0,Eructation,6,16544390
18,22.0,Haemorrhoids,6,16544390
19,22.0,Fatigue,1,16544390
20,22.0,Oropharyngeal pain,1,16544390
21,22.0,Abdominal discomfort,6,16544390
22,22.0,Product use in unapproved indication,6,16544390
23,22.0,Product dose omission,6,16544390
24,22.0,Oral pain,2,16544390
25,22.0,Paranasal sinus discomfort,1,16544390
26,22.0,Vulvovaginal discomfort,6,16544390
27,22.0,Neck pain,6,16544390
28,22.0,Anorectal discomfort,6,16544390
29,22.0,Sinusitis,6,16544390
30,22.0,Anxiety,1,16544390
31,22.0,Insomnia,6,16544390
0,22.0,Photosensitivity reaction,3,16544402
0,22.1,White blood cell count decreased,1,16544421
0,22.1,Arthralgia,3,16544427
1,22.1,Frequent bowel movements,3,16544427
2,22.1,Coccydynia,6,16544427
3,22.1,Decreased appetite,6,16544427
0,22.1,Pelvic pain,6,16544430
1,22.1,Pruritus,6,16544430
2,22.1,Dysmenorrhoea,6,16544430
3,22.1,Dry skin,6,16544430
4,22.1,Immune system disorder,6,16544430
0,22.0,Nausea,6,16544447
0,22.0,Product preparation error,6,16544489
1,22.0,Prescribed underdose,6,16544489
2,22.0,Depressed level of consciousness,5,16544489
0,22.0,Drug intolerance,,16544494
0,22.1,Pulmonary valve incompetence,6,16544495
1,22.1,Hypertension,6,16544495
2,22.1,Crying,6,16544495
3,22.1,Iron deficiency,6,16544495
4,22.1,Anxiety,6,16544495
5,22.1,Insomnia,6,16544495
6,22.1,Cough,6,16544495
7,22.1,Blood potassium decreased,6,16544495
8,22.1,Vomiting,6,16544495
9,22.1,Poor quality sleep,6,16544495
10,22.1,Fear,6,16544495
11,22.1,Bronchitis,6,16544495
12,22.1,Blood sodium decreased,6,16544495
0,22.0,Therapy cessation,,16544521
1,22.0,Disease progression,,16544521
0,22.0,Vision blurred,6,16544534
1,22.0,Seizure,6,16544534
2,22.0,Breast cancer,3,16544534
3,22.0,Malignant neoplasm progression,3,16544534
0,22.0,Death,5,16544537
0,22.0,Neuropathy peripheral,3,16544540
1,22.0,Intervertebral disc degeneration,3,16544540
2,22.0,Metastasis,3,16544540
3,22.0,Arthritis,3,16544540
4,22.0,Lipoatrophy,3,16544540
0,22.0,Febrile neutropenia,1,16544552
1,22.0,Pneumonia,1,16544552
0,22.0,General physical health deterioration,6,16544571
1,22.0,Dysphagia,6,16544571
2,22.0,Haemoptysis,6,16544571
3,22.0,Pneumothorax,6,16544571
4,22.0,Death,5,16544571
0,22.0,Pruritus,2,16544574
1,22.0,Erythema,2,16544574
0,22.1,Diarrhoea,3,16544622
1,22.1,Abdominal pain,3,16544622
2,22.1,Nausea,3,16544622
3,22.1,Disease progression,6,16544622
4,22.1,Decreased appetite,3,16544622
5,22.1,Somnolence,3,16544622
6,22.1,Feeling abnormal,3,16544622
7,22.1,Hypotension,3,16544622
8,22.1,Haemoglobin decreased,6,16544622
9,22.1,Fatigue,3,16544622
10,22.1,Vomiting,3,16544622
11,22.1,Asthenia,3,16544622
0,22.0,Unevaluable event,,16544630
0,22.0,Palliative care,6,16544633
0,22.1,Scan abnormal,6,16544654
1,22.1,Nightmare,1,16544654
2,22.1,Blood pressure increased,2,16544654
3,22.1,Anaemia,3,16544654
4,22.1,Peripheral swelling,3,16544654
5,22.1,Red blood cell count decreased,1,16544654
6,22.1,Fatigue,1,16544654
7,22.1,Vomiting,3,16544654
8,22.1,Thrombocytopenia,1,16544654
9,22.1,Dyspepsia,3,16544654
10,22.1,Anxiety,1,16544654
11,22.1,Bone marrow failure,1,16544654
12,22.1,Lymphadenopathy,6,16544654
13,22.1,Pyrexia,3,16544654
14,22.1,Migraine,6,16544654
15,22.1,Nausea,3,16544654
16,22.1,Dizziness,1,16544654
17,22.1,Off label use,6,16544654
18,22.1,Photosensitivity reaction,6,16544654
19,22.1,Constipation,3,16544654
20,22.1,Headache,3,16544654
21,22.1,Gastrooesophageal reflux disease,6,16544654
0,22.0,Nephrolithiasis,,16544681
0,22.0,Metastases to lung,6,16544695
1,22.0,Malignant neoplasm progression,6,16544695
0,22.0,Interstitial lung disease,2,16544698
0,22.0,Disease progression,,16544707
0,22.0,Altered state of consciousness,1,16544744
1,22.0,Product administration error,1,16544744
2,22.0,Respiratory depression,1,16544744
0,22.0,Abdominal pain,,16544803
0,22.0,Alopecia,3,16544806
1,22.0,Product substitution issue,3,16544806
2,22.0,Nausea,3,16544806
3,22.0,Dizziness,3,16544806
4,22.0,Fatigue,3,16544806
0,22.0,Disease progression,,16544807
0,22.0,Breast cancer stage IV,6,16544809
1,22.0,Malignant neoplasm progression,6,16544809
2,22.0,Breast cancer metastatic,6,16544809
0,22.0,Malignant neoplasm progression,6,16544901
1,22.0,Drug ineffective,6,16544901
0,22.0,Breast cancer metastatic,6,16544902
0,22.0,Product use in unapproved indication,6,16544906
1,22.0,Death,5,16544906
0,22.0,Bone marrow failure,6,16544916
1,22.0,Drug interaction,6,16544916
2,22.0,Dehydration,6,16544916
3,22.0,Fungal infection,6,16544916
0,22.0,Blood creatinine increased,6,16544922
1,22.0,Renal disorder,6,16544922
2,22.0,Renal impairment,6,16544922
0,22.0,Death,5,16544947
0,22.0,Sepsis,5,16544948
0,22.1,Hair colour changes,3,16544955
1,22.1,Hair texture abnormal,3,16544955
2,22.1,Alopecia,3,16544955
3,22.1,Hair disorder,3,16544955
4,22.1,Madarosis,3,16544955
0,22.0,Appendicitis,6,16544986
1,22.0,Prostate cancer metastatic,6,16544986
0,22.0,Neoplasm progression,6,16545006
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16545006
0,22.0,Malignant neoplasm progression,5,16545021
0,22.0,Death,,16545023
0,22.0,Malaise,,16545037
0,22.0,Arthritis,1,16545045
0,22.0,Cystitis,,16545064
0,22.0,Neoplasm progression,6,16545102
0,22.0,Death,,16545111
0,22.1,Weight decreased,6,16545139
1,22.1,Surgery,6,16545139
0,22.0,Hypotension,4,16545153
1,22.0,Atrial flutter,4,16545153
0,22.0,Diarrhoea,2,16545159
1,22.0,Hepatic function abnormal,2,16545159
0,22.0,Somnolence,3,16545191
1,22.0,Blood pressure systolic abnormal,3,16545191
2,22.0,Ill-defined disorder,3,16545191
3,22.0,Blood pressure increased,3,16545191
4,22.0,Blood pressure systolic increased,3,16545191
0,22.0,Neutropenia,5,16545249
1,22.0,Sepsis,5,16545249
0,22.0,Dyspnoea,1,16545252
1,22.0,Tachycardia,1,16545252
2,22.0,Paraesthesia oral,1,16545252
0,22.0,Neck pain,,16545277
1,22.0,Back pain,,16545277
2,22.0,Spinal pain,,16545277
3,22.0,Rhinorrhoea,,16545277
4,22.0,Sinus disorder,,16545277
5,22.0,Vision blurred,,16545277
6,22.0,Migraine,,16545277
7,22.0,Pain in extremity,,16545277
0,22.0,Purpura,2,16545328
1,22.0,Rash pruritic,2,16545328
0,22.0,Metastases to soft tissue,6,16545373
0,22.0,Interstitial lung disease,5,16545416
0,22.0,Adverse event,,16545437
0,22.0,Malaise,1,16545438
1,22.0,Chills,1,16545438
2,22.0,Abdominal pain upper,1,16545438
0,22.1,Vertigo,3,16545538
1,22.1,Dry skin,1,16545538
2,22.1,Dyspepsia,1,16545538
3,22.1,Vertigo,1,16545538
4,22.1,Dysphagia,2,16545538
5,22.1,Nausea,1,16545538
6,22.1,Pyrexia,1,16545538
7,22.1,Infusion related reaction,1,16545538
8,22.1,Off label use,6,16545538
9,22.1,Diarrhoea,1,16545538
10,22.1,Pain,2,16545538
11,22.1,Nausea,1,16545538
12,22.1,Mucosal dryness,1,16545538
0,22.0,Fatigue,5,16545689
1,22.0,Hepatic enzyme increased,6,16545689
2,22.0,Stomatitis,5,16545689
3,22.0,Dysphagia,6,16545689
0,22.0,Dysaesthesia,6,16545693
1,22.0,Dysphagia,1,16545693
2,22.0,Fatigue,1,16545693
3,22.0,Febrile neutropenia,1,16545693
4,22.0,Dysgeusia,1,16545693
5,22.0,Hypokalaemia,1,16545693
6,22.0,Performance status decreased,1,16545693
7,22.0,Diarrhoea,1,16545693
8,22.0,Palmar-plantar erythrodysaesthesia syndrome,1,16545693
9,22.0,Nausea,1,16545693
10,22.0,Off label use,6,16545693
0,22.0,Off label use,6,16545722
1,22.0,Electrocardiogram abnormal,1,16545722
0,22.0,Cataract,3,16545723
1,22.0,Dry skin,3,16545723
2,22.0,Infusion related reaction,1,16545723
3,22.0,Inflammation,1,16545723
4,22.0,Anaemia,3,16545723
5,22.0,Neutropenia,1,16545723
6,22.0,Hepatic failure,3,16545723
7,22.0,Pruritus,3,16545723
0,22.0,Vomiting,6,16545724
1,22.0,Off label use,6,16545724
2,22.0,Diarrhoea,6,16545724
3,22.0,Peripheral sensorimotor neuropathy,6,16545724
4,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16545724
5,22.0,Leukopenia,1,16545724
0,22.0,Rash,1,16545787
1,22.0,Renal impairment,6,16545787
0,22.0,Death,5,16545791
0,22.0,Product use in unapproved indication,6,16545805
0,22.1,Hypertension,3,16545810
1,22.1,Respiratory tract infection,4,16545810
2,22.1,Off label use,6,16545810
0,22.0,Epistaxis,3,16545820
1,22.0,Myalgia,3,16545820
2,22.0,Diarrhoea,3,16545820
3,22.0,Arthralgia,3,16545820
4,22.0,Muscle spasms,3,16545820
5,22.0,Lymphoedema,3,16545820
6,22.0,Cellulitis,3,16545820
7,22.0,Lacrimation increased,3,16545820
8,22.0,Nausea,3,16545820
0,22.0,Bone disorder,6,16545827
1,22.0,Schizophrenia,6,16545827
2,22.0,Bronchitis,2,16545827
3,22.0,Oropharyngeal pain,6,16545827
4,22.0,Rhinorrhoea,6,16545827
5,22.0,Tonsillitis,6,16545827
6,22.0,Influenza,6,16545827
7,22.0,Liver injury,6,16545827
8,22.0,Headache,6,16545827
9,22.0,Neoplasm progression,6,16545827
0,22.1,Lymphocyte count decreased,6,16545829
1,22.1,Haemoglobin decreased,6,16545829
2,22.1,Haematocrit decreased,6,16545829
3,22.1,Neoplasm progression,6,16545829
4,22.1,Macrocytosis,6,16545829
5,22.1,Neutrophil count decreased,6,16545829
6,22.1,Metrorrhagia,6,16545829
7,22.1,Platelet count decreased,6,16545829
8,22.1,Red cell distribution width increased,6,16545829
9,22.1,Vomiting,6,16545829
10,22.1,Nausea,2,16545829
11,22.1,White blood cell count decreased,6,16545829
12,22.1,Reticulocytosis,6,16545829
13,22.1,Red blood cell count decreased,6,16545829
0,22.0,Leukopenia,1,16545868
1,22.0,Liver function test increased,3,16545868
2,22.0,Sleep disorder,3,16545868
0,22.0,Osteonecrosis of jaw,1,16545899
1,22.0,Dyspnoea,6,16545899
2,22.0,Skin toxicity,6,16545899
3,22.0,Unevaluable event,1,16545899
0,22.1,Cardiac failure congestive,2,16545907
1,22.1,Fatigue,6,16545907
0,22.0,Neoplasm progression,6,16545927
0,22.0,Neutropenia,5,16545946
1,22.0,Pneumonia,5,16545946
0,22.0,Lung infection,3,16545975
0,22.0,Ascites,6,16546230
1,22.0,Malignant neoplasm progression,6,16546230
2,22.0,Malaise,6,16546230
3,22.0,Hepatomegaly,6,16546230
0,22.0,Metastases to central nervous system,6,16546231
0,22.0,Treatment noncompliance,6,16546284
0,22.0,Product use in unapproved indication,6,16546860
0,22.1,Abdominal pain,1,16546914
1,22.1,Haematemesis,1,16546914
2,22.1,Dizziness,1,16546914
3,22.1,Gastrooesophageal reflux disease,1,16546914
4,22.1,Rectal haemorrhage,1,16546914
5,22.1,Palpitations,1,16546914
6,22.1,Poor quality sleep,6,16546914
7,22.1,Dyspnoea,3,16546914
8,22.1,Decreased appetite,6,16546914
9,22.1,Constipation,1,16546914
10,22.1,Abdominal distension,3,16546914
11,22.1,Fatigue,3,16546914
12,22.1,Dyspepsia,1,16546914
13,22.1,Abdominal pain upper,1,16546914
14,22.1,Anaemia,2,16546914
15,22.1,Nausea,3,16546914
0,22.0,Drug resistance,6,16546920
1,22.0,Malignant neoplasm progression,6,16546920
0,22.0,Abdominal pain upper,1,16546921
1,22.0,Pyrexia,1,16546921
2,22.0,Haematocrit decreased,6,16546921
3,22.0,Basophil count decreased,6,16546921
4,22.0,Diarrhoea,1,16546921
5,22.0,Neutrophil count decreased,6,16546921
6,22.0,Lymphocyte count,6,16546921
7,22.0,White blood cell count,6,16546921
8,22.0,Epigastric discomfort,1,16546921
0,22.0,Acne,6,16546926
1,22.0,Pruritus,6,16546926
2,22.0,Hyperkeratosis,6,16546926
3,22.0,Platelet count decreased,6,16546926
0,22.0,Stevens-Johnson syndrome,2,16546945
1,22.0,Tumour associated fever,1,16546945
2,22.0,Limbic encephalitis,3,16546945
0,22.1,Constipation,1,16546998
1,22.1,Dyschezia,6,16546998
2,22.1,Proctalgia,6,16546998
3,22.1,Diarrhoea,6,16546998
4,22.1,Faeces hard,6,16546998
5,22.1,Aerophagia,6,16546998
6,22.1,Abdominal pain,6,16546998
7,22.1,Condition aggravated,1,16546998
0,22.0,Fatigue,6,16547017
1,22.0,White blood cell count decreased,6,16547017
2,22.0,Bone marrow failure,6,16547017
0,22.0,Penile exfoliation,3,16547062
1,22.0,Erythema,3,16547062
2,22.0,Skin exfoliation,3,16547062
0,22.0,Neutropenia,5,16547071
1,22.0,Sepsis,5,16547071
2,22.0,Haematochezia,6,16547071
3,22.0,Leukopenia,5,16547071
4,22.0,Ileus,5,16547071
5,22.0,Malignant neoplasm progression,6,16547071
0,22.0,Hypoaesthesia,1,16547080
1,22.0,Throat tightness,1,16547080
2,22.0,Suffocation feeling,1,16547080
0,22.0,Diarrhoea,2,16547096
1,22.0,Rash,2,16547096
2,22.0,Malignant neoplasm progression,5,16547096
3,22.0,Malignant pleural effusion,5,16547096
4,22.0,Stomatitis,1,16547096
5,22.0,Interstitial lung disease,1,16547096
0,22.0,Nodular regenerative hyperplasia,6,16547142
0,22.0,Focal nodular hyperplasia,6,16547144
0,22.0,Portal hypertension,6,16547152
1,22.0,Venoocclusive liver disease,6,16547152
2,22.0,Hepatocellular injury,6,16547152
3,22.0,Splenomegaly,6,16547152
0,22.0,Nodular regenerative hyperplasia,6,16547154
1,22.0,Focal nodular hyperplasia,6,16547154
0,22.0,Malignant neoplasm progression,6,16547471
0,22.0,Breast cancer,6,16547480
1,22.0,Malignant neoplasm progression,6,16547480
0,22.0,Psychological trauma,6,16547520
1,22.0,Alopecia,2,16547520
0,22.0,Alopecia,3,16547521
1,22.0,Anxiety,6,16547521
2,22.0,Impaired quality of life,6,16547521
3,22.0,Pain,6,16547521
4,22.0,Psychological trauma,6,16547521
5,22.0,Emotional distress,6,16547521
0,22.1,Alopecia,2,16547522
1,22.1,Psychological trauma,6,16547522
0,22.0,Emotional distress,6,16547534
1,22.0,Psychological trauma,6,16547534
2,22.0,Pain,6,16547534
3,22.0,Impaired quality of life,6,16547534
4,22.0,Alopecia,3,16547534
5,22.0,Anxiety,6,16547534
0,22.0,Alopecia,3,16547536
1,22.0,Psychological trauma,6,16547536
0,22.0,Anxiety,6,16547537
1,22.0,Alopecia,3,16547537
2,22.0,Impaired quality of life,6,16547537
3,22.0,Psychological trauma,6,16547537
4,22.0,Pain,6,16547537
5,22.0,Emotional distress,6,16547537
0,22.0,Alopecia,3,16547794
1,22.0,Psychological trauma,6,16547794
0,22.0,Dehydration,6,16548235
1,22.0,Asthenia,6,16548235
2,22.0,Ill-defined disorder,6,16548235
3,22.0,Death,5,16548235
0,22.0,Blood pressure abnormal,6,16548301
1,22.0,Myalgia,6,16548301
2,22.0,Photophobia,6,16548301
3,22.0,Dry eye,6,16548301
4,22.0,Visual impairment,6,16548301
5,22.0,Dizziness,6,16548301
6,22.0,Injection site pain,6,16548301
7,22.0,Tremor,3,16548301
8,22.0,Pleural effusion,6,16548301
9,22.0,Mental impairment,6,16548301
10,22.0,Pulse abnormal,6,16548301
11,22.0,Confusional state,6,16548301
12,22.0,Muscle swelling,6,16548301
0,22.1,Alopecia,3,16548332
0,22.1,Psychological trauma,6,16548333
1,22.1,Alopecia,2,16548333
0,22.1,Alopecia,2,16548425
0,22.0,Retinal toxicity,6,16548478
1,22.0,Drug interaction,6,16548478
0,22.0,Gastrointestinal haemorrhage,1,16548538
0,22.1,Pleuritic pain,1,16548542
1,22.1,Sepsis,1,16548542
0,22.0,Neoplasm progression,6,16548570
0,22.0,Immune system disorder,1,16548575
0,22.0,Hair colour changes,3,16548578
1,22.0,Hair disorder,3,16548578
2,22.0,Madarosis,3,16548578
3,22.0,Hair texture abnormal,3,16548578
4,22.0,Alopecia,3,16548578
0,22.0,Hair texture abnormal,3,16548580
1,22.0,Hair disorder,3,16548580
2,22.0,Alopecia,3,16548580
3,22.0,Hair colour changes,3,16548580
0,22.1,Hair colour changes,3,16548582
1,22.1,Hair disorder,3,16548582
2,22.1,Alopecia,3,16548582
3,22.1,Hair texture abnormal,3,16548582
4,22.1,Madarosis,3,16548582
0,22.0,Bone marrow failure,3,16548589
1,22.0,Hormone-refractory prostate cancer,3,16548589
0,22.0,Fatigue,2,16548657
1,22.0,Haematotoxicity,1,16548657
0,22.1,Febrile neutropenia,5,16548709
1,22.1,Pancytopenia,5,16548709
0,22.0,Breast cancer recurrent,6,16548724
0,22.0,Breast cancer recurrent,6,16548725
0,22.0,Influenza,6,16548734
1,22.0,Cardiac disorder,6,16548734
0,22.0,Pyrexia,3,16548776
1,22.0,Pneumothorax,3,16548776
2,22.0,Infectious pleural effusion,5,16548776
0,22.1,Adrenal insufficiency,1,16548794
1,22.1,Acute kidney injury,1,16548794
2,22.1,Immune-mediated enterocolitis,2,16548794
0,22.0,Cardiogenic shock,5,16548822
1,22.0,Product use in unapproved indication,6,16548822
0,22.1,Atrial fibrillation,2,16548845
0,22.0,Product use in unapproved indication,6,16548888
1,22.0,Off label use,6,16548888
0,22.0,Metastases to liver,6,16548906
1,22.0,Metastases to spine,6,16548906
2,22.0,Metastases to bone,6,16548906
3,22.0,Breast cancer metastatic,6,16548906
4,22.0,Malignant neoplasm progression,6,16548906
5,22.0,Pain,6,16548906
0,22.0,Respiratory tract infection,5,16548923
1,22.0,Diabetic ketoacidosis,2,16548923
2,22.0,Type 1 diabetes mellitus,2,16548923
0,22.1,Abdominal pain,2,16549072
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,3,16549072
2,22.1,Diarrhoea,2,16549072
0,22.0,Malignant neoplasm progression,5,16549125
0,22.0,Malignant neoplasm progression,5,16549127
1,22.0,Anaemia,1,16549127
2,22.0,Malaise,1,16549127
0,22.1,Pharyngeal ulceration,1,16549133
1,22.1,Off label use,6,16549133
2,22.1,Skin burning sensation,1,16549133
3,22.1,Respiratory failure,2,16549133
0,22.1,Febrile neutropenia,2,16549153
0,22.0,Bone pain,2,16549297
1,22.0,Dry skin,6,16549297
2,22.0,Dyspnoea,6,16549297
3,22.0,Weight decreased,6,16549297
4,22.0,Musculoskeletal chest pain,2,16549297
5,22.0,Groin pain,2,16549297
6,22.0,Fatigue,6,16549297
7,22.0,Thrombosis,1,16549297
8,22.0,Decreased appetite,6,16549297
9,22.0,Pain in extremity,2,16549297
10,22.0,Constipation,2,16549297
11,22.0,White blood cell count decreased,6,16549297
12,22.0,Oesophageal pain,2,16549297
13,22.0,Fall,6,16549297
0,22.0,Brain oedema,5,16549299
1,22.0,Fistula,6,16549299
2,22.0,Osteonecrosis of jaw,6,16549299
3,22.0,Osteoporosis,6,16549299
4,22.0,Brain abscess,5,16549299
5,22.0,Loss of consciousness,5,16549299
6,22.0,Cellulitis,6,16549299
0,22.1,Malignant neoplasm progression,6,16549430
1,22.1,Chronic obstructive pulmonary disease,6,16549430
2,22.1,Pneumonia,5,16549430
3,22.1,Gastrointestinal haemorrhage,6,16549430
0,22.0,Liver disorder,3,16549487
0,22.0,Anaemia,3,16549521
0,22.0,Accidental overdose,1,16549537
0,22.1,Prostatic specific antigen increased,6,16549668
1,22.1,Therapeutic product effect decreased,6,16549668
0,22.1,Metastases to central nervous system,3,16549738
1,22.1,Off label use,6,16549738
2,22.1,Metastases to lung,3,16549738
3,22.1,Intentional product use issue,6,16549738
0,22.0,Fatigue,3,16549741
1,22.0,Pain,3,16549741
2,22.0,Pleural effusion,3,16549741
3,22.0,Neoplasm progression,3,16549741
4,22.0,Bronchiectasis,3,16549741
0,22.1,Off label use,6,16549775
1,22.1,Intentional product use issue,6,16549775
2,22.1,Urinary tract infection,6,16549775
3,22.1,Product contamination microbial,6,16549775
0,22.0,Papilloedema,6,16549826
0,22.0,Secondary adrenocortical insufficiency,3,16549838
0,22.1,Metastases to liver,5,16549869
1,22.1,Hepatitis,5,16549869
2,22.1,Ascites,3,16549869
0,22.1,Infection,1,16549899
1,22.1,Asthma,1,16549899
2,22.1,Chronic obstructive pulmonary disease,1,16549899
3,22.1,Urinary tract infection,1,16549899
4,22.1,Drug eruption,1,16549899
5,22.1,Radiation skin injury,1,16549899
0,22.0,Liver disorder,2,16550044
1,22.0,Breast cancer recurrent,2,16550044
2,22.0,Metastases to central nervous system,2,16550044
0,22.0,Dizziness,,16550180
1,22.0,Infusion related reaction,,16550180
2,22.0,Dyspnoea,,16550180
3,22.0,Back pain,,16550180
0,22.0,Cognitive disorder,,16550445
0,22.0,Fatigue,,16550529
0,22.0,Malignant neoplasm progression,3,16550607
1,22.0,Concomitant disease aggravated,3,16550607
2,22.0,Osteoporosis,3,16550607
3,22.0,Weight decreased,3,16550607
4,22.0,Diarrhoea,3,16550607
5,22.0,Breast cancer metastatic,3,16550607
6,22.0,Lymphadenopathy,3,16550607
7,22.0,Cough,3,16550607
8,22.0,Dysphonia,3,16550607
9,22.0,Invasive lobular breast carcinoma,3,16550607
10,22.0,Metastases to lymph nodes,3,16550607
0,22.1,Infection,2,16550635
0,22.0,Breast cancer metastatic,1,16550685
1,22.0,Rash macular,1,16550685
2,22.0,Malignant neoplasm progression,1,16550685
3,22.0,Fatigue,1,16550685
0,22.0,Drug intolerance,,16550692
0,22.0,Death,,16550714
0,22.0,Malignant neoplasm progression,6,16550715
1,22.0,Breast cancer metastatic,6,16550715
0,22.0,Epistaxis,,16550716
1,22.0,Joint swelling,,16550716
2,22.0,Asthenia,,16550716
0,22.0,Gastrointestinal haemorrhage,6,16550733
0,22.0,Muscular weakness,6,16550735
1,22.0,Dyspnoea,6,16550735
0,22.1,Dissociative disorder,6,16550744
1,22.1,Hyperaesthesia,6,16550744
2,22.1,Off label use,6,16550744
3,22.1,Anxiety,6,16550744
4,22.1,Confusional state,6,16550744
5,22.1,Drug ineffective,3,16550744
6,22.1,Diplopia,6,16550744
7,22.1,Delirium,1,16550744
8,22.1,Nightmare,6,16550744
0,22.1,Fungal infection,1,16550749
1,22.1,Fatigue,6,16550749
2,22.1,Cystitis,1,16550749
3,22.1,Pruritus,1,16550749
0,22.0,Brain oedema,6,16550752
1,22.0,Localised oedema,6,16550752
2,22.0,Facial paralysis,3,16550752
0,22.0,Infusion related reaction,6,16550753
1,22.0,Extrasystoles,6,16550753
2,22.0,Hypotension,6,16550753
3,22.0,Malaise,6,16550753
0,22.0,Pleural effusion,6,16550779
1,22.0,Metastases to pleura,6,16550779
2,22.0,Breast cancer metastatic,6,16550779
3,22.0,Malignant neoplasm progression,6,16550779
0,22.0,Unintentional medical device removal,6,16550791
0,22.0,Alanine aminotransferase increased,1,16550801
1,22.0,Blood alkaline phosphatase increased,1,16550801
2,22.0,Blood bilirubin increased,1,16550801
3,22.0,Gamma-glutamyltransferase increased,1,16550801
4,22.0,Aspartate aminotransferase increased,1,16550801
0,22.0,Leukopenia,1,16550810
1,22.0,Sinusitis,1,16550810
2,22.0,Musculoskeletal chest pain,2,16550810
3,22.0,Headache,3,16550810
4,22.0,Liver function test increased,3,16550810
5,22.0,Fatigue,3,16550810
6,22.0,Bronchitis,1,16550810
7,22.0,Hyperhidrosis,2,16550810
0,22.0,Nausea,6,16550850
1,22.0,Neutropenia,6,16550850
0,22.0,Constipation,,16550889
1,22.0,Taste disorder,,16550889
2,22.0,Weight decreased,,16550889
3,22.0,Diarrhoea,,16550889
4,22.0,Paraesthesia,,16550889
0,22.0,Mouth ulceration,6,16550893
1,22.0,Bone marrow failure,6,16550893
2,22.0,Diarrhoea,6,16550893
3,22.0,Dermatitis,6,16550893
4,22.0,Hepatic function abnormal,6,16550893
0,22.0,Death,5,16550912
0,22.0,Gastric disorder,1,16550948
1,22.0,Anaemia,6,16550948
2,22.0,Gastrointestinal ulcer,1,16550948
3,22.0,Fistula of small intestine,1,16550948
4,22.0,Haematochezia,1,16550948
5,22.0,Fatigue,6,16550948
0,22.0,Blood pressure increased,1,16550969
0,22.0,Product use in unapproved indication,1,16550981
1,22.0,Off label use,1,16550981
2,22.0,Malignant neoplasm progression,6,16550981
0,22.0,Pyrexia,6,16550997
1,22.0,Dehydration,6,16550997
2,22.0,Mucosal inflammation,6,16550997
0,22.0,Acute respiratory distress syndrome,3,16550999
1,22.0,General physical health deterioration,3,16550999
2,22.0,Toxicity to various agents,3,16550999
3,22.0,Depressed level of consciousness,3,16550999
4,22.0,Cardiac failure,3,16550999
5,22.0,Inflammation,3,16550999
6,22.0,Lung infiltration,3,16550999
7,22.0,Blood pressure decreased,3,16550999
8,22.0,Respiratory failure,3,16550999
9,22.0,Diarrhoea,3,16550999
10,22.0,Bone marrow failure,3,16550999
11,22.0,Stomatitis,3,16550999
0,22.0,Therapeutic response decreased,6,16551036
1,22.0,Malignant neoplasm progression,6,16551036
2,22.0,Breast cancer,6,16551036
0,22.0,Disease progression,,16551079
0,22.0,Cytopenia,2,16551118
0,22.0,Off label use,6,16551152
1,22.0,Proctalgia,6,16551152
0,22.0,Left ventricular hypertrophy,6,16551157
1,22.0,Mitral valve incompetence,6,16551157
2,22.0,Ventricular hypertrophy,6,16551157
3,22.0,Cardiac hypertrophy,6,16551157
4,22.0,Cardiac failure chronic,6,16551157
5,22.0,Systolic dysfunction,6,16551157
6,22.0,Chest discomfort,6,16551157
7,22.0,Ejection fraction decreased,6,16551157
0,22.0,Malaise,3,16551173
1,22.0,Death,5,16551173
2,22.0,Bone pain,3,16551173
3,22.0,Dehydration,3,16551173
4,22.0,Off label use,6,16551173
5,22.0,Pain in jaw,3,16551173
0,22.0,Anaemia,6,16551202
1,22.0,Hypoalbuminaemia,6,16551202
0,22.0,Drug interaction,6,16551216
1,22.0,Hypoglycaemia,1,16551216
0,22.0,Breast cancer metastatic,6,16551242
1,22.0,Therapeutic product effect incomplete,6,16551242
0,22.0,Hyperglycaemia,6,16551269
0,22.0,Infection,5,16551286
0,22.0,Hypokinesia,6,16551310
1,22.0,Movement disorder,6,16551310
2,22.0,Hypersomnia,6,16551310
0,22.0,Diarrhoea,6,16551311
1,22.0,Neutropenia,6,16551311
2,22.0,Polyneuropathy,6,16551311
0,22.0,Deafness,6,16551322
0,22.0,Liver function test increased,6,16551339
1,22.0,Hepatitis,6,16551339
2,22.0,Drug ineffective,6,16551339
3,22.0,Malignant neoplasm progression,6,16551339
0,22.0,Dependence on oxygen therapy,6,16551355
0,22.0,Death,5,16551369
0,22.0,Breast cancer metastatic,6,16551376
1,22.0,Malignant neoplasm progression,6,16551376
2,22.0,Neoplasm progression,6,16551376
0,22.0,Abdominal pain,6,16551385
1,22.0,Injection site pain,6,16551385
0,22.0,Neutrophil count decreased,2,16551396
1,22.0,Nausea,2,16551396
2,22.0,Diarrhoea,2,16551396
0,22.0,Breast cancer metastatic,6,16551410
1,22.0,Malignant neoplasm progression,6,16551410
0,22.1,Off label use,6,16551421
1,22.1,Intentional product use issue,6,16551421
2,22.1,Pulmonary hypertension,6,16551421
0,22.0,Malignant neoplasm progression,6,16551456
1,22.0,Drug ineffective,6,16551456
2,22.0,Breast cancer,6,16551456
0,22.0,Malignant neoplasm progression,6,16551459
1,22.0,Breast cancer metastatic,6,16551459
0,22.0,Breast cancer metastatic,6,16551460
0,22.0,Arteriovenous fistula,1,16551472
1,22.0,Diarrhoea,1,16551472
0,22.0,Neutropenic sepsis,2,16551481
1,22.0,Pain in extremity,6,16551481
2,22.0,Rash,6,16551481
3,22.0,Pyrexia,6,16551481
0,22.0,Chills,1,16551574
1,22.0,Hyperpyrexia,1,16551574
0,22.1,Wound,3,16551651
1,22.1,Infection,3,16551651
2,22.1,Immune system disorder,1,16551651
0,22.0,Osteonecrosis,1,16551661
0,22.0,Ileal perforation,1,16551744
1,22.0,Shock,6,16551744
0,22.0,Pneumonia,6,16551761
1,22.0,Neoplasm progression,6,16551761
0,22.0,Death,5,16551773
0,22.0,Fatigue,3,16551774
1,22.0,Hypotension,3,16551774
2,22.0,Depressed mood,3,16551774
0,22.0,Delirium,1,16551778
1,22.0,Drug ineffective,,16551778
2,22.0,Anxiety,6,16551778
0,22.0,Renal failure,1,16551809
1,22.0,Invasive ductal breast carcinoma,6,16551809
0,22.0,Unresponsive to stimuli,6,16551813
1,22.0,Nausea,6,16551813
2,22.0,Vomiting,6,16551813
0,22.0,Visual impairment,6,16551817
1,22.0,Photophobia,6,16551817
2,22.0,Blood pressure increased,6,16551817
3,22.0,Aphasia,6,16551817
0,22.0,Malignant neoplasm progression,5,16551822
1,22.0,Myopathy,2,16551822
0,22.0,Death,5,16551897
0,22.0,Death,5,16551912
0,22.0,Product dose omission,6,16551913
1,22.0,Death,5,16551913
0,22.1,Cerebellar haemorrhage,5,16551956
0,22.0,Transaminases increased,2,16552027
1,22.0,Hepatotoxicity,6,16552027
2,22.0,Blood bilirubin increased,6,16552027
0,22.0,Anaemia,1,16552030
1,22.0,Abdominal pain,1,16552030
0,22.0,Abdominal distension,3,16552031
1,22.0,General physical health deterioration,3,16552031
2,22.0,Asthenia,3,16552031
0,22.0,Hepatotoxicity,6,16552038
1,22.0,Asthenia,6,16552038
2,22.0,Anaemia,6,16552038
3,22.0,Thrombocytopenia,6,16552038
4,22.0,Neuropathy peripheral,6,16552038
5,22.0,Arthralgia,6,16552038
